These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 10264746

  • 1. A strategy to reduce drug expenditures with a drug utilization review program.
    Hoffmann RP.
    Hosp Pharm; 1984 Jan; 19(1):7-8, 11-2. PubMed ID: 10264746
    [Abstract] [Full Text] [Related]

  • 2. Development and implementation of a comprehensive, criteria-based drug-use review program.
    Todd MW, Keith TD, Foster MT.
    Am J Hosp Pharm; 1987 Mar; 44(3):529-35. PubMed ID: 3471089
    [Abstract] [Full Text] [Related]

  • 3. Cost containment through P & T committee drug utilization review.
    Bender FH, DeMatteo CS.
    Hosp Formul; 1984 Aug; 19(8):699-700, 705-7. PubMed ID: 10267391
    [Abstract] [Full Text] [Related]

  • 4. Impact of a target drug monitoring program on the usage of clindamycin.
    Gin AS, Lipinski LA, Honcharik N.
    Can J Hosp Pharm; 1994 Apr; 47(2):53-8. PubMed ID: 10134127
    [Abstract] [Full Text] [Related]

  • 5. Effect of antibiotic order form guiding rational use of expensive drugs on cost containment.
    Sirinavin S, Suvanakoot P, Sathapatayavongs B, Malatham K.
    Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):636-42. PubMed ID: 10437971
    [Abstract] [Full Text] [Related]

  • 6. The development and implementation of a drug utilization review program.
    Lazor-Bajcar JM, Fowler R.
    Can J Hosp Pharm; 1988 Feb; 41(1):11-6. PubMed ID: 10286608
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cost containment through therapeutic substitution of aminoglycosides.
    Guernsey BG, Berina LF, Lazarus MC, Hokanson JA, Prohaska C, Allen JA, Doutre WH, Mader JT.
    Hosp Pharm; 1985 Feb; 20(2):82-3, 86-92, 95. PubMed ID: 10270312
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacy-laboratory interactions: a unique method to control antibiotic costs.
    Goff D, Thornton J.
    Hosp Pharm; 1989 Jan; 24(1):26-9, 32. PubMed ID: 10291600
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Controlling financial variables--changing prescribing patterns.
    Abramowitz PW.
    Am J Hosp Pharm; 1984 Mar; 41(3):503-15. PubMed ID: 6367444
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacy management strategies for responding to hospital reimbursement changes.
    Curtiss FR.
    Am J Hosp Pharm; 1983 Sep; 40(9):1489-92. PubMed ID: 6353913
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Intravenous metronidazole: a drug utilization review in a community hospital.
    Nessim D.
    Can J Hosp Pharm; 1987 Feb; 40(1):6-11. PubMed ID: 10281259
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.